Print / Electronic
Written remarks accompanying Managing Director Rob Carlson’s remarks at the White House Bioeconomy Summit (PDF); Official Summit Summary from White House (PDF). See also, “Biotech experts gather at the White House for ‘Summit on America’s Bioeconomy’”, Alan Boyle, Geekwire, 7 October, 2019.
“The engineering of living organisms could soon start changing everything” (PDF), Oliver Morton, The Economist, 4 April, 2019. (This issue of the Technology Quarterly features several of our portfolio companies, as well as our latest economic analysis of U.S. bioeconomy revenues.)
"Cell therapies are giving Seattle an edge in biotech, driving three acquisitions in under a month", Clare McGrane, Geekwire, 28 February 2018.
"The Biobased Economy Is Reaching a Tipping Point", Brent Erickson, Biofuels Digest, 26 February 2018.
"How DNA could store all the world’s data in a semi-trailer", Chloe Cornish, Financial Times, 4 February 2018.
"Bioeconomy Capital's Rob Carlson sees big potential in Seattle's industrial biotech startups", Casey Coombs, Puget Sound Business Journal, 13 December 2017.
"With Lab-Grown Leather, Modern Meadow Is Engineering a Fashion Revolution", Vikram Alexei Kansara, Business of Fashion, 26 September 2017.
"Why Every Company Needs A Bio Strategy", Rob Wright, Life Science Leader, 6 Oct 2017.
"New Natural Selection: How Scientists Are Altering DNA To Genetically Engineer New Forms Of Life", Bryan Walsh, Newsweek, 29 June, 2017.
"How a biotech startup rose, and then fell", Scott Kirsner, Boston Globe, 20 Jan 2017.
"Forget the sci-fi horror stories. Here’s what we could learn from a synthetic genome", Ike Swetlitz, STAT News, 2 June 2016.
"DNA Manufacturing Enters the Age of Mass Production", Eliza Strickland, IEEE Spectrum, 23 Dec 2015.
VIDEO
Biology is Technology: David Lang Interviews Rob Carlson
Writes David Lang:
Rob Carlson wrote the book on our biotech future more than ten years ago.
"We could be going much faster," he replied, when asked what surprised him most about the last decade in biology.
He matches his deep involvement in biotechnology research and development with a broad understanding of innovation history. While no one can precisely predict the future, Carlson draws the best map.
Engineering a Sustainable Future: Investment Opportunities in the Bioeconomy
Webinar recorded in July, 2020.
"How can we give humanity the chance to choose how to manufacture [everything] in a cleaner, greener way?"
This webinar and panel discussion describe opportunities for qualified investors interested in the bioeconomy, biotechnology, and renewable manufacturing. Bioeconomy Funds 1 & 2 are now closed to new investment.
Note that Zymergen is now a public company, and Edenworks has been renamed Upward Farms.
ENGINEERING OUR WAY TO A SUSTAINABLE BIOECONOMY
Congressional Testimony by Rob Carlson, U.S. House of Representatives, Subcommittee on Research and Technology,
12 March, 2019
Written Testimony: “Engineering Our Way to a Sustainable Bioeconomy”, Robert Carlson. (PDF)
Answers to Follow Up Questions Submitted by Chairwoman Haley Stevens, Robert Carlson (PDF)